TOXOIDING OF SNAKE VENOM AND EVALUATION OF IMMUNOGENICITY OF THE TOXOIDS

Similar documents
NOTES IMMUNOGENICITY IN MONKEYS OF A COMBINED TOXOID FROM THE MAIN TOXIC PRINCIPLES SEPARATED FROM HABU SNAKE VENOM

Gye and Cramer (1919) found that the ionizable salts of calcium injected together with the washed spores of Cl. tetani or of certain

. Analgesics and antipyretics (tabkt mefanemic acid

Neutralization of Micrurus distans distans venom by antivenin (Micrurus fulvius)

ON HABU SNAKE VENOM 1. COMPARISON OF SEVERAL BIOLOGICAL ACTIVITIES OF FRESH AND DRIED HABU SNAKE VENOM

VENOMS OF CORAL SNAKES (MICRURUS SPP.): REPORT ON A MULTIVALENT ANTIVENIN FOR THE AMERICAS

6/20/2018. A Public Benefit Corporation. A First-in-Class Snakebite Antidote. Discovery to Accelerated Development

5 Dangerous Venom Types Thailand Snakes. Thailand Snake Venom Types:

Materials and Methods: Anti-snake venom activities of Asparagus racernosus

Contact Immunization. is now being done to improve methods. and technics of control. in the past in most countries, and if

Diurnal variation in microfilaremia in cats experimentally infected with larvae of

ff2 REFJPORT: Final Report-~Vs ~

Venom Research at Natural Toxins Research Center (NTRC)

Venomous Snakebite in Mountainous Terrain: Prevention and Management

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

AD A STUDY ON THE PROPHYLACTIC TOXOID AGAINST VENOM OF ASIAN SNAKES. Yoshio Sawai. Japan Snake Center Yabuzuka, Japan.

Mouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.

Summary of product characteristics As per Annex C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1

Influence of Mouse Strain on the Assayed Potency (Unitage) of Tetanus Toxoid

Antitoxin l.evels in Botulism Patients Treated with Trivalent Equine Botulism Antitoxin to Toxin Types A, B, and E

(D) fertilization of eggs immediately after egg laying

Error! Reference source not found. I. SUMMARY OF PRODUCT CHARACTERISTICS

Anti4ody Response to Successive Booster Doses of Tetanus

The Effect of Enzyme Treatments on Brucella abortus Cell Walls

Maharashtra, India. snake venom poisoning for animal experiment. The root of Vitex trifolia is

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

VENOMOUS SNAKE BITES IN LAO PDR: A RETROSPECTIVE STUDY OF 21 SNAKEBITE VICTIMS IN A PROVINCIAL HOSPITAL

Envenomation by the hump nosed viper (hypnale hypnale) in children: a pilot study

SNABIRC-KENYA A GUIDE TO MANAGING SNAKEBITES

Management of Snake Bite in Saudi Arabia

Medically important snakes in Sri Lanka

Bovine Brucellosis Control of indirect ELISA kits

STUDIES ON HATCHABILITY OF SCHISTOSOMA JAPONICUM EGGS IN SEVERAL EXTERNAL ENVIRONMENTAL CONDITIONS

Procedures for the Taking of Preventive and Eradication Measures of Brucellosis for Swine

Clostridial Vaccination Efficacy on Stimulating and Maintaining an Immune Response in Beef Cows and Calves 1,2

FRACTIONATION AND DETOXIFICATION OF NAJA NAJA VENOM, PREPARATION OF ANTI TOXOID - IGY ANTIBODIES AND IN VITRO NEUTRALIZATION STUDIES

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SCHEDULE P LIFE PERIOD OF DRUGS. [See rule 96] Conditions of storage

Regional vs Systemic Antivenom Administration in the Treatment of Snake Venom Poisoning in a Rabbit Model: A Pilot Study

Production, Optimization of Detoxification and Ammonium Sulphate Precipitation of Ultrafiltered Tetanus Toxin

ESTIMATES OF DISEASE BURDEN DUE TO LAND-SNAKE BITE IN SRI LANKAN HOSPITALS

Clinical Profile of Snake Bite in Children in Rural India. Vinayak Y. Kshirsagar, MD; Minhajuddin Ahmed, MD; Sylvia M.

66 ISSN East Cent. Afr. J. surg

Malayan Pit Viper Venomous Very Dangerous

The Most Venomous Dangerous Deadly Poisonous Snakes?

By the end of this lecture students will be able to understand Importance, epidemiology, pathogenesis of snake bite Clinical manifestations

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

zation and labor when large groups are than toxoid injections in adults, although second method is of great value, but it

Burn Infection & Laboratory Diagnosis

Photos. Photos Collection COBRA SNAKE PHOTOS. King Cobra (Ophiophagus hannah) [Page Updated: 8 May 2017]

Bites by non-native venomous snakes in the United States

UT HEALTH EMERGENCY MEDICINE & TRAUMA GUIDELINES

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya

antibody test Voller (1963) have shown both in vitro and in vivo that the third stage of Ascaris larvae of man and

1 iv. 00 lad I 00 EDGEW00D ARSENAL ^ TECHNICAL REPORT. DOSE-RESPONSE RELATIONSHIP OF CRUDE COBRA VENOM {Naja naja) IN THE DOG

DOWNLOAD OR READ : THE POISONOUS SNAKES OF INDIA FOR THE USE OF THE OFFICIALS AND OTHERS RESIDING IN THE INDIAN EMPIRE PDF EBOOK EPUB MOBI

Snake bites in Nigeria: A study of the prevalence and treatment in Benin City

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

3 RD INTERNATIONAL SUMMIT ON TOXICOLOGY & APPLIED PHARMACOLOGY OCTOBER 20-22, 2014 CHICAGO, USA

Banded Krait Venomous Deadly

Influences on tetanus immunization in

SNAKE ENVENOMATION. RYAN DE VOE DVM, MSpVM, DACZM, DABVP-Avian. Modified by Michael R.Loomis, DVM, MA, DACZM North Carolina Zoological Park

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

University of Malaya. From the SelectedWorks of Fung Shin Yee Fung Shin Yee. Fung Shin Yee, Fung Shin Yee, University of Malaya

International Journal of Pharma and Bio Sciences STANDARDIZATION OF ELISA AS A TEST FOR ESTIMATION OF ASVS IN EQUINE SERA

Paul-Ehrlich-Institut Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel Federal Institute for Vaccines and Biomedicines

THE EFFICACY OF HYPERIMMUNE SERUM IN THE TREATMENT OF SWEATING SICKNESS

DP.1. Control tables

DP.1. Control tables

INFECTIOUS ABORTION INVESTIGATIONS

Use of a novel adjuvant to enhance the antibody response to vaccination against Staphylococcus aureus mastitis in dairy heifers.

IJBCP International Journal of Basic & Clinical Pharmacology

ASVCP quality assurance guidelines: veterinary immunocytochemistry (ICC)

ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis

SUMMARY OF PRODUCT CHARACTERISTICS

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT

WHO/SEARO GUIDELINES FOR THE CLINICAL MANAGEMENT OF SNAKE BITES IN THE SOUTHEAST ASIAN REGION

An objective approach to antivenom therapy and assessment of rst-aid measures in snake bite

VIPERIDAE. Adult Teo Eng Wah. Wirot's Palm Pit Viper (EN) Trimeresurus wiroti. MyBIS: IUCN Red List GPAV HPAV. Least Concern (LC)

Compliance. Should you have any questions, please contact Praveen Pabba, Ph.D., ( or

THE INFLUENCE OF STREPTOCOCCUS ALLER- GEN AND STREPTOLYSIN 0 ON THE FORMA- TION OF ANTITETANUS IMMUNITY DISTRIBUTED BY:

SUMMARY OF PRODUCT CHARACTERISTICS

Detection of early pregnancy in sheep by the rosette inhibition test

Antivenom Cross-Neutralization of the Venoms of Hydrophis schistosus and Hydrophis curtus, Two Common Sea Snakes in Malaysian Waters


EVALUATION OF THE SENSITIVITY AND SPECIFICITY OF THE EHRLICHIA CANIS DIAGNOSTIC TEST: Anigen Rapid E.canis Ab Test Kit

Effect of Some Variables on the in vivo Determination of Scorpion and Viper Venom Toxicities

Delayed reporting to health care facilities: a significant determinant of fatalities in cases of snake bites

The Action of Tetanus Toxin in Frogs

EU Statistical Data of all uses of animals

EU Statistical Data of all uses of animals

Clinical Features, Management and Outcome of Snake Bite in Children in Manipal Teaching Hospital

POST-OPERATIVE ANALGESIA AND FORMULARIES

Standards relating to the Care and Keeping and Reducing Pain of. Laboratory Animals (Notice of the Ministry of the Environment

The Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary

Sera from 2,500 animals from three different groups were analysed:

Snake-Bite Present Scenario In Bangladesh. Dr A K M Humayon Kabir Associate professor Dept. of Medicine Dhaka Medical College

Approved by the Food Safety Commission on September 30, 2004

Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys

Transcription:

TOXOIDING OF SNAKE VENOM AND EVALUATION OF IMMUNOGENICITY OF THE TOXOIDS Pages with reference to book, From 9 To 13 Zahid Husain Khan ( Present Addressc Chief Research Officer, Pakistan Medical Research Council, 162/O/IH, P.E.C.H.S. Karachi. ) Faiyaz Ahmed Lari, Zafar Ali ( Biological Production Division, National Health Laboratories, Islamabad. ) Abstract The venom of Pakistan species of snakes (Naja naja, Vipera russelli and Echis carinatus) and lethal fractions of Cobra (Naja naja) venom were converted to toxoid with formalin. Detoxification of the crude venoms and toxic fraction was attained by addition of formalin in several steps and incubation at 37 C maintaining the ph 7.0. Relationship of formalin concentration and incubation period was studied. The detoxified product retained immunogenicity as revealed by titrating the circulating antitoxin and response of the animals immunized with the crude venom toxoids when challenged with homologous venoms. Vipera russelli and Echis carinatus anti sera neutralized 10 and 15 M.H.D. respectively and on challenging immunized animals with homologous venoms of Naja naja, vipera russelli and Echis carinatus survived 5-10 MLD of the respective venoms. The lethal fraction toxoid of cobra showed lesser immunogenicity (JPMA 30: 9, 1980). Introduction It is estimated that in Pakistan snake bite deaths occur in the range of 10,000 to 12,000 annually (Minton 1968). They are mostly due to Cobra (Naja naja), Russel's Viper (Vipera russelli) saw scaled viper (Echis carinatus) and Kraits (Bangarus cerealis and B. candid us). The rural population of the country and the army in strategic movements are much exposed to the bites of these snakes. There are no protective measures against the venomous effects of the bites of these snakes except post-exposure therapy with hyperimmune serum and other supportive therapy. Sero-therapy has its own limitations. It is effective only when applied soon after the snake bite before manifestation of tissue damage. In most of the cases it is too late when the anti-venom is available to the victim of the snake bite. Moreover the reactions occurring in certain cases have their own hazards. People prone to the hazards of the snakes bites could be protected by active immunization if immunogenic toxoids of snakes venoms could be prepared and used. The Biological Production Division of the National Health Laboratories, Islamabad, manufactured monovalent and polyvalent hyperimmune sera of the above named Pakistan species of snake venoms for post exposure therapy. Preparation of immunogenic toxoid (s) of snake venom (s) for active immunization was undertaken as a research project by the Division. Preparation of a toxoid of snake venom involves complete detoxification of the venom and at the same time retention of immunogenicity of the product at its maximum. As reported by Kondo et al (1971) attempts of toxoid-ing the snake venoms by treatment with formalin or other chemicals, by irradiation with x-rays and/or by photo-oxidation by a number of workers had only partial success as detoxification was attained but the immunogenicity was impaired. Attempts at preparation of highly immunogenic toxoids of three kinds of venoms by graded treatment with increasing concentrations of formalin following the methods of Sadahiro et al (1970) and Kondo et al (1971) were made and briefly reported by Khan et al (1977).

Material and Methods Snake Venoms: The venoms used were pools of lypholized venom batches of Cobra Naja naja, Russell's Viper (Vipera russelli)and Echis carinatus. The lethal fraction of Cobra venom (fraction pool III) was obtained by column chromatography on CM. Cellulose as reported earlier (Khan et al., 1974). Determination of Toxicity: The lethal toxicity of all the three venoms and the lethal fraction III of cobra venom were determined (separately) by intervenous injections into mice of 16-18 gms body weight and expressed in terms of LD5o whereas the hemorrhagic activity was determined by intracutaenous injections into depleted skins of rabbits and expressed in terms of MHD. (Minimum Hemorrhagic Dose) following the methods of Kondo et al (1960) and Khan et al (1973, 1974). DetoRification of crude venom: Each of the crude venoms of Cobra, Russell Viper and Echis carinatus was dissolved in 30 M phosphate buffer saline (ph 7.0) to make 1% solution. Detoxification of the venom solutions was carried out following the methods of Sadahiro et al (1970) and Kondo et al (1971). Aliquots of venom solutions were treated with formalin 0.2%, 0.4%, 0.6% and 0-8%. The final formalin concentrations were attained by increasing concentration by 0.2% on every alternate day. Similarly lethal fraction pool III of cobra venom isolated earlier (Khan et al., 1974) was treated with formalin by increasing concentration of 0.2% finally reaching the maximum level of 0.8%. The formalinized venom solutions were incubated at 37 C for a maximum period of 21 days maintaining the ph at 7.0 using N/ I NaOH solution. The course of detoxification was studied on 3, 5, 7, 10, 14 and 21 days after the addition of formalin. For the experimental purpose a part of the forma-linising solution (crude venom toxoid) and also that of Cobra lethal fraction III toxoid was dialized in cellophane tubing at 2-4 C in buffered saline (ph 7.0) to remove excess of formalin. The toxicities of both dialized and undialized toxoids were determined at intervals by intravenous injections into mice of 16-18 gms body weight, as shown in Table I. Immunization with the toxoids: Guinea pigs weighing 350-450 gms and rabbits weighing 1500-1600 gms body weight were immunized with each toxoid preparation per immunization schedule (Table II). After complete cycle of immunization the animals were bled and circulating anti toxin titres and ED5o of immunized sera were determined following the methods of Kondo et al (1965, 1971). Immunogenicity tests of the toxoids: Standard monovalent antivenom that is a hyperimmune horse serum, prepared by the Biological Production Division of the National Health Laboratories, Islamabad against Cobra, Russell's viper and Echis carinatus venoms were used as standard antivenin in the experiments for titration of circulating antitoxins of the sera obtained from the animals immunized with the toxoids. Units of anti-sera were determined by the method introduced by Ipsen (1942)- As such the units of monovalent anti serum of cobra, Russell's viper and Echis carinatus were established and kept at 200 units/ml after carrying out the neutralizing effects of the serum concerned on the toxicity of corresponding venom in a series of mice injected by the intravenous route with mixtures in which amounts of the serum were varying but the amount of antigen (venoms) was maintained constant. The number of deaths occurring in the mice within an interval of 24 hrs upto 5 days were utilized in the calculation, since mice receiving injections containing much free toxin (venom) die more rapidly than mice receiving injections containing small amounts of free toxin (venom). Since there are no international standard anti-sera against Russel's viper and Echis carinatus determination of relationship between the units of anti-sera of our laboratory with the international standard was not possible. Each serum specimen of Russell's viper and Echis carinatus toxoid was titrated for anti-hemorrhagic activity as the Cobra venom is devoid of hemorrhagic activity (Ohsaka et al., 1966; Yang, 1965; Khan et al., 1974). Gel-diffusion test on microscopic slides and precipitation tests in capillary tubes were also carried out for qualitative determination of the presence of corresponding anti-bodies in the sera of the immunized guinea pigs and rabbits using homologous and heterologous venom solutions. Positive controls were also maintained in all the tests using corresponding monovalent antivenin.

The other groups of immunized animals (guinea pigs and rabbits) were challenged 10' days after the last injection with 2-10 M.L.D. of respective crude venom by intramuscular injections in thigh muscles. Results The snake venom solutions treated with formalin at concentrations ranging from 0.2 to 0.8 and incubation at 36-37\ C for a maximum period of 21 days resulted in detoxification at a concentration as low as 0.2%. At concentrations 0.6% and 0.8% detoxifications were attained by 14th and 10th day respectively (Fig. 1). The course of detoxification collectively is depicted graphically (Fig. I) and detoxification test results at the level of 0.6% and 0.8% formalin treatment are summarized in Table I.

Immunization schedule of animals (rabbits and guinea pigs) with toxoids has been elaborated in Table II.

The results of circulating anti-toxin titres and ED estimations of immunized sera of rabbits and guinea pigs with formal toxoids of Cobra, Russell's viper and Echis carinatus are summarized in Table III. Precipitations in capillary tubes and gel diffusion tests performed with the sera of the immunized animals with the toxoids gave positive results as shown in Table IV. The gel diffusion and precipitation tests showed distinct precipitating bands for toxoids of Russell's viper and Echis carinatus using homologous venoms whereas somewhat diffused precipitation bands were observed in case of Cobra toxoid immunized sera. This is probably for the reason that the cobra venom is less antigenic as compared to Russell's viper and Echis carinatus venoms. No cross reactions were observed, in the animals immunized with toxoids.

Table V shows that immunized animals, rabbits and guinea pigs challenged with the 2-10 MLD doses of corresponding venoms were protected. In table VI it may be noted that Russell's viper serum has the capacity to neutralize 10 MHD homologous venom where Echis carinatus anti-serum neutralized 15 MHD with its homologous venom. MHD of Russell's viper and Echis carinatus venoms was determined as per methods of Ohsaka et al (1966)

The cobra venom lethal fraction pool III toxoid was detoxified as the crude cobra venom but the toxoid elicited poor antigenicity. In diffusion test clear precipitation bands could be observed only upto 1/10 dilution. The immunized rabbits could survive with challenge of 5 MLD only and at higher challenge dose the animal did not survive. The immunogenic response in guinea-pig was not exhibited at this challenge dose. Discussion Detoxification of snake venoms irrespective of snake species were achieved on treatment with low concentration of formalin and incubation at temperature of 37 C and ph 7.0. Formalin concentration and incubation period have inverse relationship as lesser the concentration the longer the incubation period and with increasing concentration the incubation time was shortened. This is in agreement with the finding of Sadahiro et al (1970) and Kondo et al (1971). The crude venoms detoxified with gradually at increasing concentrations by 0.2% and finally reaching at 0.6% and 0.8% on tests have shown that the preparation retained the immunogenicity. The anti-sera of the toxoids exhibited anti-toxin qualitatively by precipitation and gel diffusion tests. The immunized animals survived 5-10 MLD challenge doses of respective venoms and the anti-sera neutralized 10-15 MHD doses of Russell's viper and Echis carinatus venoms. The toxoids of lethal fraction of cobra venom (Fraction pool III) was less immunogenic as compared with crude venom toxoid. References 1. Ipsen, J. (1942) Systematische and Zufallige Fehler-quellen bei Messung Kleiner Antitoxinmengen; teta-nusantitoxin. Ztschr. f. Immunitatsforsch. J. Exper. Therap., 102:347. 2. Khan, Z.H., Jan, Z.A. and Ahmad, M. (1973) Fractionation of Russellis viper venom by chromatography on CM. Cellulose with special reference. Japan J. Med. Sc. Biol., 26:39. 3. Khan, Z.H., Lari, FA. and Ali, Z. (1977) Preparation of toxoids from the venoms of Pakistan species of snake, (Naja naja), Vipera russelli and Echis carinatus. Japan J. Med. Sc. Biol., V. 30:19. 4. Kondo, H., Kondo, S., Ikezawa, H., Murata, R. and Ohsaka, A. (1960) Studies on the quantitative method for determination of hemorrhagic activity of Habu snake venom. Japan J. Med. Sc. Biol., 13:43. 5. Khan, Z.H., Jan. Z.A., Zaidi, T.A. and Faruqui, A.Q. (1974) Fractionation of Cobra venom on C.M. Cellulose with special reference to biological activities. Japan J. Med. Sc. Biol., 27:49. 6. Kondo, H., Kondo, S., Sadahiro, S., Yamauchi, K., Ohsaka, A. and Murata, R. (1965) Standardization of antivenin. I. A method for determination of anti-lethal potency of Habu antivenin. Japan J. Med. Sc. Biol., 18:101. 7. Kondo, H., Kondo, S., Sadahiro, S., Yamauchi, K., Ohsaka, A. and Murata, R. (1965) Standardization of antivenin. II. A method for determination of anti-hemorrhagic potency of Habu antivenin in the presence of two hemorrhagic principles and their antibodies. Japan J. Sc. Biol., 18:127. 8. Kondo, S., Sadahiro, S., Yamauchi, K., Kondo, H. and Murata, R. (1971) Preparation and standardization of toxoid from the venom of Trimeresurus flavo-viridis (Habu). Japan J. Med. Sc. Biol., 24:181. 9. Cecil, R.L.F. Cecil Leeb textbook of medicine. 12th ed. edited Paul B. Beeson and Walsh McDermott, Philadelphia, Saunders, 1967, pp. 420-6. 10. Ohsaka, A. (1960) Fractionated of Habu snake venom by chromatography on CM. Cellulose with special reference to biological activities. Japan J. Med. Sc. Biol., 13:193. 11. Ohsaka, A., Omori-Satok, Y., Kondo, H., Kondo, S. and Murata, R. (1966) Biochemical and

pathological aspects of hemorrhagic principle in snake venoms with special reference to Habu (Trimeresurus flavovi-ridis) venom. Mem. Inst. Butantan, 33:193. 12. Reed, L.J. and Muinch, H. (1938) A simple method of estimating fifty per cent and points. Am. J. Hyg., 27:493. 13. Sadahiro, S., Kondo, S., Yamauchi, K., Kondo, H. and Murata, R. (1970) Studies on immunogenicity of toxoid from Habu (Trimeresurus flavoviridis) venom. Japan J. Med. Sc. Biol., 23:285. 14. Yang, C. (1965) Crystallization and properties of cobrotoxin from formosan cobra venom. J. Biol. Chem., 240:1616.